📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
In 2025, Jubilant Pharmova completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Jubilant Pharmova has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Jubilant Pharmova’s data sources below and access millions more through our Disclosure Search.
In 2025, the total operational greenhouse gas (GHG) emissions ofJubilant Pharmova amounted to74,303metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Jubilant Pharmovadecreased by 3.22%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2025, the total Scope 1 emissions of Jubilant Pharmova were 10,084 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Compared to the previous year(2024), Jubilant Pharmova's Scope 1 emissions increased by 16.98%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2025, Jubilant Pharmova reported Scope 2 greenhouse gas (GHG) emissions of 64,219 tCOâ‚‚e without specifying the calculation method.a
Compared to the previous year(2024), Jubilant Pharmova's Scope 2 emissions(Unspecified Calculation Method) have remained relatively stable, indicating that Jubilant Pharmova's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2025, Jubilant Pharmova reported its Scope 2 emissions using an unspecified methodology.a
In 2025, Jubilant Pharmova reported 527,407 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2025 disclosure of Jubilant Pharmova includes a breakdown across 0of the 15 Scope 3 categories defined by the GHG Protocol,matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2025, Jubilant Pharmova reported total Scope 3 emissions of 527,407 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Compared to the previous year (2024), Jubilant Pharmova's Scope 3 emissions decreased by 28.46%, highlighting the company's efforts to lower indirect emissions from its value chain.a
In 2025, Jubilant Pharmova reported Scope 1 greenhouse gas (GHG) emissions of 10,084 tCOâ‚‚e and total revenues of USD 842 millions. This translates into an emissions intensity of 11.98 tCOâ‚‚e per millions USD.a
In 2025, Jubilant Pharmova reported a Scope 1 emissions intensity of 11.98 tCOâ‚‚e per millions USD. Compared to the peer group median of 24.05, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2025, Jubilant Pharmova ranked 6 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
Jubilant Pharmova is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
In 2025, Jubilant Pharmova reported a total carbon footprint of 601,710 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 26.08% decrease compared to 2024, indicating progress in reducing its overall greenhouse gas output.a
The largest contributor to Jubilant Pharmova's total carbon footprint was Scope 3 emissions, accounting for 87.65% of the company's total carbon footprint, followed by Scope 2 emissions at 10.67%.a